DENTSPLY SIRONA Inc
NASDAQ:XRAY
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
17.26
37.39
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc
Cash & Cash Equivalents
DENTSPLY SIRONA Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash & Cash Equivalents
$296m
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Cash & Cash Equivalents
$299.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
22%
|
CAGR 10-Years
9%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Cash & Cash Equivalents
$312.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash & Cash Equivalents
$1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
16%
|
CAGR 10-Years
19%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash & Cash Equivalents
$866.4m
|
CAGR 3-Years
112%
|
CAGR 5-Years
62%
|
CAGR 10-Years
41%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Cash & Cash Equivalents
$523.1m
|
CAGR 3-Years
97%
|
CAGR 5-Years
70%
|
CAGR 10-Years
55%
|
|
DENTSPLY SIRONA Inc
Glance View
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in York, Pennsylvania and currently employs 15,000 full-time employees. The firm develops, manufactures and markets solutions, including dental equipment and dental consumable products. The Company’s segments include Technologies & Equipment (T&E) and Consumables. The T&E segment is engaged in designing, manufacturing, sales and distribution of its Dental Technology and Equipment Products and Healthcare Consumable Products. Its products include dental implants, computer-aided design/computer-aided manufacturing systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as consumable medical device products. The Consumables segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Consumable Products, which include preventive, restorative, endodontic and dental laboratory products. The company also offers treatment planning and a clear aligner solution delivered directly to a consumer's home.
See Also
What is DENTSPLY SIRONA Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
296m
USD
Based on the financial report for Sep 30, 2024, DENTSPLY SIRONA Inc's Cash & Cash Equivalents amounts to 296m USD.
What is DENTSPLY SIRONA Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
12%
Over the last year, the Cash & Cash Equivalents growth was -4%. The average annual Cash & Cash Equivalents growth rates for DENTSPLY SIRONA Inc have been 2% over the past three years , 6% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
